Bo Situ
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Biomedical Engineering top 2%
- Nanoplatforms for cancer theranostics
- Biosensors and Analytical Detection
Papers in
-
- MicroRNA in disease regulation 14
-
- Advanced biosensing and bioanalysis techniques 35
- Extracellular vesicles in disease 19
- RNA Interference and Gene Delivery 9
Bo Situ
88 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 130
- Cancer Research 601
- Biomedical Engineering 1.3k
- Molecular Biology 1.9k
- Materials Chemistry 958
- Spectroscopy 250
Countries citing papers authored by Bo Situ
This map shows the geographic impact of Bo Situ's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Situ with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Situ more than expected).
Fields of papers citing papers by Bo Situ
This network shows the impact of papers produced by Bo Situ. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Situ. The network helps show where Bo Situ may publish in the future.
Co-authors
The 25 scholars most cited alongside Bo Situ, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2025 | 3 | |
| 6 | 2024 | 10 | |
| 7 | 2023 | 11 | |
| 8 | 2023 | 38 | |
| 9 | 2023 | 14 | |
| 10 | 2023 | 15 | |
| 11 | 2022 | 41 | |
| 12 | 2022 | 32 | |
| 13 | 2021 | 32 | |
| 14 | 2021 | 14 | |
| 15 | 2021 | 39 | |
| 16 | 2020 | 24 | |
| 17 | 2020 | 47 | |
| 18 | 2020 | 15 | |
| 19 | 2020 | 40 | |
| 20 | 2019 | 65 |
About Bo Situ
Bo Situ is a scholar working on Cancer Research, Molecular Biology, Biomedical Engineering, Health Informatics and Microbiology, having authored 91 papers that have together received 3.1k indexed citations. Recurring topics across this work include Advanced biosensing and bioanalysis techniques (35 papers), Extracellular vesicles in disease (19 papers), Nanoplatforms for cancer theranostics (17 papers), MicroRNA in disease regulation (14 papers), Luminescence and Fluorescent Materials (13 papers), Biosensors and Analytical Detection (11 papers), RNA Interference and Gene Delivery (9 papers) and Advanced Nanomaterials in Catalysis (6 papers). The work is most often cited by research in Cancer Research (601 citations), Biomedical Engineering (1.3k citations), Molecular Biology (1.9k citations), Materials Chemistry (958 citations) and Spectroscopy (250 citations). Bo Situ has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Lei Zheng, Bo Li, Taixue An, Ben Zhong Tang, Weilun Pan, Chunchen Liu, Shihua Luo, Ye Zhang, Shuhuai Yao and Yu Hu. Their work appears in journals such as Biosensors and Bioelectronics, Analytica Chimica Acta, Sensors and Actuators B Chemical, Clinica Chimica Acta and Journal of Extracellular Vesicles.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.